HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy

Molecular Pharmaceutics

Volumn 8, Issue 5, 2011, Pages 1669-1676

  Quan, Qimeng ^a,b   Xie, Jin ^b   Gao, Haokao ^b   Yang, Min ^b   Zhang, Fan ^b   Liu, Gang ^b   Lin, Xin ^b   Wang, Andrew ^c   Eden, Henry S ^b   Lee, Seulki ^b   Zhang, Guixiang ^a   Chen, Xiaoyuan ^b  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c OCEAN NANOTECH LLC   (United States)

Author keywords

breast cancer; doxorubicin; drug delivery; iron oxide nanoparticle; magnetic resonance imaging; theranostic nanomedicine

Indexed keywords

DOXORUBICIN; HUMAN SERUM ALBUMIN; IRON OXIDE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CELL MEMBRANE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; FEMALE; FLUORESCENCE MICROSCOPY; FOLLOW UP; HYDRODYNAMICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FEMALE; FERRIC COMPOUNDS; HALF-LIFE; METAL NANOPARTICLES; MICE; MICE, NUDE; PHYSICOCHEMICAL PHENOMENA; SERUM ALBUMIN; SURFACE PROPERTIES; TISSUE DISTRIBUTION; TUMOR BURDEN;

EID: 80053507349     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200006f     Document Type: Article

References (28)

1. Xie, J.; Lee, S.; Chen, X. Nanoparticle-based theranostic agents Adv. Drug Delivery Rev. 2010, 62, 1064-79
2. Lukianova-Hleb, E. Y.; Oginsky, A. O.; Samaniego, A. P.; Shenefelt, D. L.; Wagner, D. S.; Hafner, J. H.; Farach-Carson, M. C.; Lapotko, D. O. Tunable plasmonic nanoprobes for theranostics of prostate cancer Theranostics 2011, 1, 3-17
3. Jeong, H.; Huh, M.; Lee, S. J.; Koo, H.; Kwon, I. C.; Jeong, S. Y.; Kim, K. Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy Theranostics 2011, 1, 230-9
4. Huang, P.; Xu, C.; Lin, J.; Wang, C.; Wang, X.; Zhang, C.; Zhou, X.; Guo, S.; Cui, D. Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy Theranostics 2011, 1, 240-50
5. Xie, J.; Liu, G.; Eden, H. S.; Ai, H.; Chen, X. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy Acc. Chem. Res. 2011, 10.1021/ar200044b
6. Xie, J.; Huang, J.; Li, X.; Sun, S.; Chen, X. Iron oxide nanoparticle platform for biomedical applications Curr. Med. Chem. 2009, 16, 1278-94
7. Corot, C.; Robert, P.; Idee, J. M.; Port, M. Recent advances in iron oxide nanocrystal technology for medical imaging Adv. Drug Delivery Rev. 2006, 58, 1471-504 (Pubitemid 44820503)
8. 4 nanoparticles for targeted delivery and controlled release of cisplatin J. Am. Chem. Soc. 2009, 131, 10637-44
9. Piao, Y.; Kim, J.; Bin Na, H.; Kim, D.; Baek, J. S.; Ko, M. K.; Lee, J. H.; Shokouhimehr, M.; Hyeon, T. Wrap-bake-peel process for nanostructural transformation from beta-FeOOH nanorods to biocompatible iron oxide nanocapsules Nat. Mater. 2008, 7, 242-247 (Pubitemid 351313823)
10. Yang, X.; Grailer, J. J.; Rowland, I. J.; Javadi, A.; Hurley, S. A.; Steeber, D. A.; Gong, S. Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging Biomaterials 2010, 31, 9065-73
11. Guthi, J. S.; Yang, S. G.; Huang, G.; Li, S.; Khemtong, C.; Kessinger, C. W.; Peyton, M.; Minna, J. D.; Brown, K. C.; Gao, J. MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells Mol. Pharmaceutics 2010, 7, 32-40
12. Jain, A. K.; Swarnakar, N. K.; Das, M.; Godugu, C.; Singh, R. P.; Rao, P. R.; Jain, S. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model Mol. Pharmaceutics 2011, 8, 1140-51
13. Yu, M. K.; Jeong, Y. Y.; Park, J.; Park, S.; Kim, J. W.; Min, J. J.; Kim, K.; Jon, S. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo Angew. Chem., Int. Ed. 2008, 47, 5362-5
14. Erten, A.; Wrasidlo, W.; Scadeng, M.; Esener, S.; Hoffman, R.; Bouvet, M.; Makale, M. Magnetic resonance and fluorescence imaging of doxorubicin-loaded nanoparticles using a novel in vivo model Nanomedicine 2010, 6, 797-807
15. Meng, H.; Xue, M.; Xia, T.; Ji, Z.; Tarn, D. Y.; Zink, J. I.; Nel, A. E. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of Doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model ACS Nano 2010, 5, 4131-44
16. Conlin, A. K.; Seidman, A. D.; Bach, A.; Lake, D.; Dickler, M.; DAndrea, G.; Traina, T.; Danso, M.; Brufsky, A. M.; Saleh, M.; Clawson, A.; Hudis, C. A. Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer Clin. Breast Cancer 2010, 10, 281-7
17. Iglesias, J. nab-Paclitaxel (Abraxane(R)): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors Breast Cancer Res. 2009, 11 (Suppl. 1) S21
18. Xie, J.; Chen, K.; Huang, J.; Lee, S.; Wang, J.; Gao, J.; Li, X.; Chen, X. PET/NIRF/MRI triple functional iron oxide nanoparticles Biomaterials 2010, 31, 3016-22
19. Gradishar, W. J. Albumin-bound paclitaxel: a next-generation taxane Expert Opin. Pharmacother. 2006, 7, 1041-53 (Pubitemid 43949942)
20. Paal, K.; Muller, J.; Hegedus, L. High affinity binding of paclitaxel to human serum albumin Eur. J. Biochem. 2001, 268, 2187-91 (Pubitemid 32852961)
21. Jain, T. K.; Reddy, M. K.; Morales, M. A.; Leslie-Pelecky, D. L.; Labhasetwar, V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats Mol. Pharmaceutics 2008, 5, 316-27 (Pubitemid 351579134)
22. Guide for the Care and Use of Laboratory Animals; National Academy Press: Washington, DC, 1996.
23. MacKay, J. A.; Chen, M.; McDaniel, J. R.; Liu, W.; Simnick, A. J.; Chilkoti, A. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection Nat. Mater. 2009, 8, 993-9
24. Xie, J.; Wang, J.; Niu, G.; Huang, J.; Chen, K.; Li, X.; Chen, X. Human serum albumin coated iron oxide nanoparticles for efficient cell labeling Chem. Commun. (Cambridge) 2010, 46, 433-5
25. Park, J.; An, K. J.; Hwang, Y. S.; Park, J. G.; Noh, H. J.; Kim, J. Y.; Park, J. H.; Hwang, N. M.; Hyeon, T. Ultra-large-scale syntheses of monodisperse nanocrystals Nat. Mater. 2004, 3, 891-895
26. Dreis, S.; Rothweiler, F.; Michaelis, M.; Cinatl, J., Jr.; Kreuter, J.; Langer, K. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles Int. J. Pharm. 2007, 341, 207-14 (Pubitemid 47088104)
27. Chen, K.; Xie, J.; Chen, X. RGD-human serum albumin conjugates as efficient tumor targeting probes Mol. Imaging 2009, 8, 65-73
28. Cai, C.; Lothstein, L.; Morrison, R. R.; Hofmann, P. A. Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198) J. Pharmacol. Exp. Ther. 2010, 335, 223-30